Primary Prevention

"Primary Prevention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Specific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from SECONDARY PREVENTION and TERTIARY PREVENTION.

Descriptor ID	D011322
MeSH Number(s)	N02.421.726.758 N06.850.780.680
Concept/Terms	Primary Prevention Primary Prevention Disease Prevention, Primary Disease Preventions, Primary Primary Disease Prevention Primary Disease Preventions Prevention, Primary Primordial Prevention Primordial Prevention Preventions, Primordial Primordial Preventions Prevention, Primordial

Below are MeSH descriptors whose meaning is more general than "Primary Prevention".

Health Care [N]
Health Care Facilities, Manpower, and Services [N02]
Health Services [N02.421]
Preventive Health Services [N02.421.726]
Primary Prevention [N02.421.726.758]
Environment and Public Health [N06]
Public Health [N06.850]
Public Health Practice [N06.850.780]
Primary Prevention [N06.850.780.680]

Below are MeSH descriptors whose meaning is more specific than "Primary Prevention".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Primary Prevention" by people in this website by year, and whether "Primary Prevention" was a major or minor topic of these publications.

Bar chart showing 63 publications over 22 distinct years, with a maximum of 6 publications in 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	2	3
2003	2	3	5
2004	0	4	4
2005	1	4	5
2006	0	3	3
2007	1	0	1
2008	2	3	5
2009	1	2	3
2010	2	4	6
2011	1	4	5
2012	1	0	1
2013	1	0	1
2014	3	1	4
2015	0	1	1
2016	2	0	2
2017	0	1	1
2018	3	1	4
2019	1	0	1
2020	0	4	4
2021	1	0	1
2022	0	2	2
2024	1	0	1

Below are the most recent publications written about "Primary Prevention" by people in Profiles.

Bao A, Karalis DG. Statin Therapy for Primary and Secondary Prevention in Older Adults. Curr Atheroscler Rep. 2024 Nov 25; 27(1):11.

View in: PubMed
Wright AK, Carr MJ, Kontopantelis E, Leelarathna L, Thabit H, Emsley R, Buchan I, Mamas MA, van Staa TP, Sattar N, Ashcroft DM, Rutter MK. Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. Diabetes Care. 2022 04 01; 45(4):909-918.

View in: PubMed
Tai WA. Stroke: Primary Prevention. FP Essent. 2022 Jan; 512:11-17.

View in: PubMed
Krebs J, Mansi T, Delingette H, Lou B, Lima JAC, Tao S, Ciuffo LA, Norgard S, Butcher B, Lee WH, Chamera E, Dickfeld TM, Stillabower M, Marine JE, Weiss RG, Tomaselli GF, Halperin H, Wu KC, Ashikaga H. CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia (CERTAINTY). Sci Rep. 2021 11 22; 11(1):22683.

View in: PubMed
LeBoff MS, Murata EM, Cook NR, Cawthon P, Chou SH, Kotler G, Bubes V, Buring JE, Manson JE. VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population. J Clin Endocrinol Metab. 2020 09 01; 105(9).

View in: PubMed
Gaibazzi N, Suma S, Lorenzoni V, Sartorio D, Pressman G, Siniscalchi C, Garibaldi S. Myocardial Scar by Pulse-Cancellation Echocardiography Is Independently Associated with Appropriate Defibrillator Intervention for Primary Prevention after Myocardial Infarction. J Am Soc Echocardiogr. 2020 09; 33(9):1123-1131.

View in: PubMed
Lindemann F, Oebel S, Paetsch I, Arya A, Dagres N, Richter S, Dinov B, Hilbert S, Loebe S, Stegmann C, Doering M, Bollmann A, Hindricks G, Jahnke C. Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms. J Cardiovasc Magn Reson. 2020 05 11; 22(1):32.

View in: PubMed
Manson JE, Bassuk SS, Cook NR, Lee IM, Mora S, Albert CM, Buring JE. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence. Circ Res. 2020 01 03; 126(1):112-128.

View in: PubMed
Maggi P, De Socio GV, Cicalini S, D'Abbraccio M, Dettorre G, Di Biagio A, Martinelli C, Nunnari G, Rusconi S, Sighinolfi L, Spagnuolo V, Squillace N. Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use. AIDS Res Ther. 2019 05 24; 16(1):11.

View in: PubMed
Romero J, Díaz JC, Grushko M, Quispe R, Briceno D, Avendano R, Golive A, Pina I, Natale A, Garcia MJ, Jorde UP, Di Biase L. Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials. Europace. 2018 09 01; 20(FI2):f211-f216.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement